Pfizer gives September hope for Covid-19 vaccine


American biopharmaceutical company, Pfizer said its COVID-19 vaccine could be ready for emergency use by September.


The company plans to begin testing of the experimental vaccine in the US next week.

This is coming a week after Germany approved human trial of a possible COVID-19 vaccine. The vaccine, named BNT162, was developed by Biontech, a Mainz-based company. The company said the vaccine would be tested in the US after human trials in Germany.

The United Kingdom had also announced that there would be clinical trials of a potential COVID-19 vaccine.

The World Health Organisation, WHO, said there are about 20 different potential COVID-19 vaccines currently in development.


Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the pandemic may last till 2021.